Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Peeling paint, shoddy cleanups among issues at U.S. plant making J&J COVID-19 vaccine - FDA

Stock MarketsApr 21, 2021 06:05PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the NYSE in New York 2/2

By Carl O'Donnell and Julie Steenhuysen

(Reuters) - A U.S. plant that was making Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine must fix a long list of problems including peeling paint, shoddy cleanups, and poorly-trained staff to resume operation, according to a highly critical report by the Food and Drug Administration.

Experts said addressing the issues raised in the scathing FDA inspection report could take months.

Neither J&J nor the FDA has said when they expect vaccine production to resume at the Baltimore plant owned by Emergent Biosolutions (NYSE:EBS) Inc. Only one plant, in the Netherlands, is currently producing the key drug substance used in J&J's vaccine, the company said.

"It may take many months to make these changes," said Prashant Yadav, a global healthcare supply-chain expert at the Center for Global Development. He described some of the issues raised by the FDA as "quite significant."

J&J said it would ensure that all of the FDA issues are addressed promptly and comprehensively.

The 12-page report described dirty facilities and many instances of potential contamination. In some cases, employees carrying unsealed medical waste collided with containers used to make material for vaccines, it noted, adding that containers had been spotted elsewhere with cracks.

Problems were not investigated and cleanups were superficial, it added. In one example, a worker moved between rooms where different materials were being made on 19 different days while only documenting a single required shower, the report said.

FDA inspectors said the facility was not large enough, describing crowded rooms difficult to walk through without bumping into containers of materials and small doors that forced workers to push containers on the ground rather than use machines to carry them.

"Paint flecks were observed on the floor all along the sides of these walls" on corridors surrounding the manufacturing room and in a room were vials were filled, it said in one section, adding that there was "brown residue" on the wall and "black residue" on the floor in one plant room.

The investigation confirmed media reports that J&J shots made at the Emergent plant had been contaminated with material used to make vaccine for AstraZeneca (NASDAQ:AZN). At the time, workers responded to the mix up with little more than a routine cleaning, it noted.

Millions of J&J doses were ruined, the New York Times reported. Production of AstraZeneca's vaccine was moved elsewhere.

"There is no assurance that other batches have not been subject to cross-contamination," the report said.

J&J has drawn scrutiny for months over its halting process to scale up production of the one-shot vaccine that is easier to handle and use than other authorized vaccines.

Its use in the United States has been paused since last week as health officials study a possible link to a very rare but serious blood clot condition.

Emergent has been seeking regulatory authorization to make the J&J vaccine in the United States. It stopped production at the plant recently, saying the FDA had asked it to do so after an inspection.

"What's important is that the FDA caught these deficiencies" and took steps to ensure the vaccine produced there was not used, said vaccine researcher Dr. Anna Durbin of Johns Hopkins University in Baltimore.

"Emergent has some work to do to clean up their process. They will likely need to be re-inspected by the FDA before any vaccine produced there would be accepted," she said.

Johnson & Johnson reiterated on Wednesday that it was working to establish a global supply chain in which 10 manufacturing sites would be involved in production of its COVID-19 vaccine, in addition the Netherlands plant.

The company has a U.S. government-brokered agreement with rival drugmaker Merck & Co, which is preparing to make doses of J&J's vaccine.

FAILURE TO TRAIN PERSONNEL

The inspection report said the FDA team had reviewed security camera footage in addition to an in-person site visit to the Emergent plant.

It found failure to train personnel to avoid cross contamination of COVID-19 vaccines from Johnson & Johnson and AstraZeneca.

Earlier this week, the U.S. House Representatives launched an investigation into whether Emergent used its relationship with a Trump administration official to get a vaccine manufacturing contract despite a record of not delivering on contracts.

Emergent said in a statement that it is working with the FDA and J&J to quickly resolve the issues outlined in the report.

The inspection, carried out between April 12 and April 20, also noted that Emergent did not produce adequate reports showing that the vaccines it was producing met quality standards.

J&J said it was redoubling its efforts to get authorization for the facility as quickly as possible.

J&J's oversight could help Emergent better address the FDA's concerns, none of which are especially difficult to fix, Cantor Fitzgerald analyst Brandon Folkes said in a note.

No vaccine manufactured at the Baltimore plant has been distributed for use in the United States.

Peeling paint, shoddy cleanups among issues at U.S. plant making J&J COVID-19 vaccine - FDA
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (9)
Saleen Sharma
Saleen Sharma Apr 22, 2021 3:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great news, they font care about life only elwants to make money.Worse company
Daniel Hodel
Daniel Hodel Apr 21, 2021 10:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not surprising. Another American company where business ethics means nothing, and profits are everything.
Bobster Bambino
Bobster Bambino Apr 21, 2021 3:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not surprising for a company that needs to advertise they care about consumer. What a joke.
Felipe Daniel
Felipe Daniel Apr 21, 2021 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very assuring on the high quality of the jabs.
Ad Cline
Ad Cline Apr 21, 2021 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Danny levine...keep that thought, and maybe covid will solve your problems for you.
Ad Cline
Ad Cline Apr 21, 2021 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
j and j has a reputation for cutting corners and lying to the public. if the're invoved, there always seems to be some sort of ********up. I think the government needs to distance itself from this company if they want a successful vaccine production program.
Ad Cline
Ad Cline Apr 21, 2021 11:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
felipe Daniel ....are you still working for the Russians
Felipe Daniel
Felipe Daniel Apr 21, 2021 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dr Fauci has to keep lying because he is financially connected to the jab makers.
danny Levine
danny Levine Apr 21, 2021 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol those trusting vaccines are so out of whack
Benjamin McIntire
Benjamin McIntire Apr 21, 2021 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Danny whats life like being so afraid of everything? Scarediepants :( ;(
Felipe Daniel
Felipe Daniel Apr 21, 2021 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Benjamin McIntire why did jab manufacturers receive immunity if everything is so safe?
Gary Moses
Gary Moses Apr 21, 2021 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Felipe Daniel youre Scared Also Felipe. WOW
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email